Koers Mesa Laboratories, Inc.
Aandelen
MLAB
US59064R1095
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
100,7 USD | +1,12% | -4,07% | -3,85% |
Omzet 2024 * | 212 mln. 199 mln. | Omzet 2025 * | 235 mln. 221 mln. | Marktkapitalisatie | 543 mln. 510 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 2 mln. 1,88 mln. | EV/omzet 2024 * | 2,57 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,31 x |
K/w-verhouding 2024 * |
-1.832
x | K/w-verhouding 2025 * |
269
x | Werknemers | 698 |
Dividendrendement 2024 * |
0,64% | Dividendrendement 2025 * |
0,64% | Vrij verhandelbaar | 94,26% |
1 dag | +1,12% | ||
1 week | -4,07% | ||
Lopende maand | -8,19% | ||
1 maand | -1,02% | ||
3 maanden | +10,44% | ||
6 maanden | +2,17% | ||
Lopend jaar | -3,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gary Owens
CEO | Chief Executive Officer | 56 | 20-03-17 |
John Sullivan
CHM | Chairman | 71 | 01-10-04 |
John Sakys
DFI | Director of Finance/CFO | 55 | 29-10-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Sullivan
CHM | Chairman | 71 | 01-10-04 |
Mark Capone
BRD | Director/Board Member | 61 | 05/01 |
R. Tripeny
BRD | Director/Board Member | 65 | 23-06-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 100,7 | +1,12% | 27 080 |
18-04-24 | 99,62 | -1,50% | 31 078 |
17-04-24 | 101,1 | -1,33% | 30 554 |
16-04-24 | 102,5 | -1,87% | 26 434 |
15-04-24 | 104,4 | -0,53% | 29 969 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,85% | 543 mln. | |
-2,53% | 186 mld. | |
-3,52% | 106 mld. | |
+5,33% | 50,39 mld. | |
+16,43% | 47,65 mld. | |
-1,73% | 39,29 mld. | |
+5,66% | 27,24 mld. | |
-2,01% | 25,42 mld. | |
+9,84% | 24,39 mld. | |
-1,87% | 24,54 mld. |